safest glp-1 drugs Agonists Explained: Definition, How They Work, Side Effects America's Poison Centers - GLP-1

Summary Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits

This is not just about neuroprotection

MODD1 earned FDA clearance for MODD1 in September 2024

Overweight and obesity are defined by the World Health Organization as having a body mass index (BMI) 25 253 million global disability-adjusted life years, 6.5 million deaths and almost 62 million years lived with disability from CKD, resulting in a higher global BMI-related burden for CKD than for other conditions traditionally linked to obesity, such as colorectal cancer [4]